Peptide Based Therapeutics Summit

Temi della conferenza
Positioned in the goldilocks spot between small molecules and biologics, peptide therapeutics have undergone an exciting uphill trajectory within the last decade. Fuelled by advances in synthesis and screening technologies, together with novel design and delivery strategies to surmount their inherent drawbacks, this modality is showing new levels of promise.

Professional congress organizer (PCO)
Hanson Wade

Annotazioni
URL:
Brochure: https://go.evvnt.com/2184892-3?pid=4832

Speakers: Andy Slee, Chief Scientific Officer, Protagenic Therapeutics, Cameron Pye, Chief Executive Officer, Unnatural Products, and more

https://go.evvnt.com/2184892-2?pid=4832

Ms. Alice Grant